TRPM8 antagonists (Johnson & Johnson)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTRPM8 antagonists (Johnson & Johnson)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily M member 8 antagonists
TargetsTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsPainNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsN/A
Inactive IndicationsPainNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A